Amanote Research

Amanote Research

    RegisterSign In

Considering Adjuvant Therapy for Stage II Melanoma

Cancer - United States
doi 10.1002/cncr.32585
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

December 23, 2019

Authors
Andrew S. PoklepovicJason J. Luke
Publisher

Wiley


Related search

Adjuvant Therapy: Melanoma

Journal of Skin Cancer
DermatologyOncology
2011English

Us Burden of Illness Associated With Adjuvant Therapy for Stage I-Iii Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Adjuvant Therapy in Stage II Colon Cancer: Current Approaches

Oncologist
Cancer ResearchMedicineOncology
2005English

Update on Adjuvant Melanoma Therapy

Current Opinion in Oncology
Cancer ResearchOncology
2018English

P-0218 * Timing and Regimens of Adjuvant Therapy for Resected Stage Ii and Iii Colon Cancer

Annals of Oncology
MedicineOncologyHematology
2014English

ASO Author Reflections: Frequent Relapses Prior to the Start of Adjuvant Therapy in Stage IIIB/C Melanoma

Annals of Surgical Oncology
OncologySurgery
2019English

Adjuvant Radiation for Malignant Melanoma

Kansas Journal of Medicine
2008English

Postoperative Adjuvant Therapy for Advanced Carcinoma of Tongue (Stage Iii and Iv)

Japanese jornal of Head and Neck Cancer
2002English

Does Adjuvant Therapy Make a Difference for Stage 1A Type 2 Endometrial Cancer?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy